002513 蓝丰生化
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-35.431-499.896-874.338-173.591-62.622
总资产报酬率 ROA (%)-0.348-4.826-7.406-13.631-20.021
投入资产回报率 ROIC (%)-0.883-11.794-18.985-33.734-40.021

边际利润分析
销售毛利率 (%)6.1243.132-2.139-2.0500.652
营业利润率 (%)-4.860-12.131-22.508-19.905-12.487
息税前利润/营业总收入 (%)-2.679-10.352-21.652-18.793-16.619
净利润/营业总收入 (%)-4.238-11.604-19.699-19.966-22.190

收益指标分析
经营活动净收益/利润总额(%)93.35469.94468.92671.56648.214
价值变动净收益/利润总额(%)-20.928-0.821-0.277-8.923-0.935
营业外收支净额/利润总额(%)-0.1392.0537.1842.16226.930

偿债能力分析
流动比率 (X)0.6710.6950.5600.6260.347
速动比率 (X)0.6010.6050.4820.5590.253
资产负债率 (%)91.43492.07090.85792.62775.766
带息债务/全部投入资本 (%)72.60072.87471.25281.30231.711
股东权益/带息债务 (%)3.7743.1583.4272.337175.560
股东权益/负债合计 (%)1.0801.0601.0470.80131.986
利息保障倍数 (X)-1.232-5.094-8.335-12.111-35.379

营运能力分析
应收账款周转天数 (天)93.15672.80865.66947.41321.561
存货周转天数 (天)37.29638.04434.41826.92128.928